Interestingly, IL-9 was recently shown to promote the survival and function of human melanoma-infiltrating CD4+CD8+ double-positive T cells [44] (Fig. 1), lending further support to the hypothesis that IL-9 may amplify anti-tumor immune responses by promoting T cell fitness in human melanoma. The gene discussed is CD8A; the disease is neoplasm.